scholarly article | Q13442814 |
P2093 | author name string | Philip Gehrman | |
Michael L Perlis | |||
Wilfred R Pigeon | |||
Sara E Matteson-Rusby | |||
P2860 | cites work | Long-term follow-up of chronic insomnia | Q70896702 |
Self-reported sleep disturbance as a prodromal symptom in recurrent depression | Q73230264 | ||
Insomnia in Young Men and Subsequent Depression: The Johns Hopkins Precursors Study | Q73528843 | ||
Who becomes depressed? The Islington community study of older people | Q73712954 | ||
Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits | Q24538295 | ||
Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia | Q24646517 | ||
Major Depressive Disorder (MDD) is associated with a primary defect within the serotonergic system | Q30763180 | ||
The efficacy of cognitive-behavioral therapy for insomnia in patients with chronic pain | Q33695720 | ||
Insomnia and heart disease: a review of epidemiologic studies | Q33806559 | ||
Insomnia: epidemiology, characteristics, and consequences | Q33974032 | ||
Prevalence and treatment of insomnia in general practice. A longitudinal study. | Q34061310 | ||
A cognitive model of insomnia | Q34145119 | ||
Treatment of chronic insomnia by restriction of time in bed. | Q34183910 | ||
Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy | Q34330624 | ||
Does sleep disturbance predict depression in elderly people? A study in inner London | Q34348545 | ||
Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults | Q34386642 | ||
Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia | Q34482283 | ||
Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? | Q34541877 | ||
Measuring outcomes in randomized clinical trials of insomnia treatments | Q35202824 | ||
Do insomnia complaints cause hypertension or cardiovascular disease? | Q35995401 | ||
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations | Q35995568 | ||
Discrepancy between subjective symptomatology and objective neuropsychological performance in insomnia. | Q35995607 | ||
Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? | Q36519119 | ||
The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review | Q36523437 | ||
Treating the health, quality of life, and functional impairments in insomnia | Q36844267 | ||
Cancer-related fatigue and sleep disorders | Q36851046 | ||
Incidence and risk factors of insomnia in a population-based sample. | Q37279090 | ||
Intermittent and long-term use of sedative hypnotics. | Q37347409 | ||
The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. | Q37388190 | ||
Insomnia as a risk factor for onset of depression in the elderly | Q38438197 | ||
A behavioral perspective on insomnia treatment | Q39702869 | ||
Treatment of insomnia in cancer patients using muscle relaxation training | Q40163657 | ||
Treatment of residual insomnia after CBT for PTSD: case studies | Q40373577 | ||
Economic effects of insomnia. | Q40595288 | ||
Secondary insomnia: diagnostic challenges and intervention opportunities | Q40610274 | ||
Sleep complaints and depression in an aging cohort: A prospective perspective | Q40784276 | ||
Identifying effective psychological treatments for insomnia: a meta-analysis | Q40995161 | ||
An evaluation of progressive muscle relaxation on stress related symptoms in a geriatric population | Q41642024 | ||
Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy | Q41673576 | ||
Insomnia in primary care patients | Q41677388 | ||
Short and long sleep and sleeping pills. Is increased mortality associated? | Q44106715 | ||
Depression and insomnia. | Q44313209 | ||
The morbidity of insomnia uncomplicated by psychiatric disorders | Q44319923 | ||
The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression | Q44395380 | ||
Persistent insomnia is a predictor of hypertension in Japanese male workers | Q44694024 | ||
Persistence and remission of depressive symptoms in late life | Q44777563 | ||
Behavioral management of sleep disturbances secondary to chronic pain | Q45004883 | ||
Randomized controlled trial of brief cognitive-behavioural interventions for insomnia in recovering alcoholics. | Q45022775 | ||
Medical and socio-professional impact of insomnia. | Q45239747 | ||
Sleep problems and their correlates in a working population | Q46153581 | ||
The natural history of insomnia: a population-based 3-year longitudinal study | Q48406814 | ||
Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. | Q48466083 | ||
The direct and indirect costs of untreated insomnia in adults in the United States | Q48472282 | ||
A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. | Q48475550 | ||
A pilot study of cognitive-behavioral therapy of insomnia in people with mild depression | Q48477368 | ||
Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus | Q48490097 | ||
Effects of a brief behavioral treatment for PTSD-related sleep disturbances: a pilot study | Q48497178 | ||
The economic impact of insomnia in managed care: a clearer picture emerges. | Q48501412 | ||
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder | Q48506440 | ||
The economic cost of sleep disorders. | Q48508358 | ||
Secondary insomnia: a myth dismissed | Q48519355 | ||
Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial | Q48522790 | ||
Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects | Q48536988 | ||
Focusing on the experience of insomnia | Q48557296 | ||
Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluation | Q48601739 | ||
Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer | Q48635386 | ||
Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up | Q48637645 | ||
Efficacy of two behavioral treatment programs for comorbid geriatric insomnia | Q48659195 | ||
Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors | Q48684266 | ||
Imagery rehearsal therapy for chronic nightmares in sexual assault survivors with posttraumatic stress disorder: a randomized controlled trial | Q48685848 | ||
Behavioral treatment of insomnia: treatment outcome and the relevance of medical and psychiatric morbidity | Q48689778 | ||
Relationship between insomnia, depression, and mortality: a 12-year follow-up of older adults in the community | Q48710007 | ||
Cognitive-behavioral treatment of insomnia secondary to chronic pain | Q48718537 | ||
Psychological treatment of secondary insomnia | Q48718664 | ||
The direct economic costs of insomnia in the United States for 1995. | Q48755598 | ||
Quality of life in people with insomnia. | Q48755632 | ||
Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. | Q48755783 | ||
Behavioral treatment of chronic insomnia in psychiatrically ill patients | Q48773151 | ||
Sleep onset insomnia, sleep maintaining insomnia and insomnia with early morning awakening--temporal stability of subtypes in a longitudinal study on general practice attenders | Q48834764 | ||
Physical activity and personal characteristics associated with depression and suicide in American college men. | Q48854153 | ||
Sleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline | Q48899594 | ||
Affective symptoms associated with the onset of major depression in the community: findings from the US National Institute of Mental Health Epidemiologic Catchment Area Program | Q48903334 | ||
The Zurich study. VIII. Insomnia: association with depression, anxiety, somatic syndromes, and course of insomnia | Q48930193 | ||
Automobile accidents in patients with sleep disorders | Q48934059 | ||
The treatment of severe insomnia in a cancer patient | Q49017117 | ||
Behavioral treatment of excessive daytime sleepiness in an elderly woman with multiple medical problems | Q49061589 | ||
Therapeutic application of a simple relaxation method. | Q51305958 | ||
Inpatient multidimensional management of treatment-resistant insomnia. | Q52074872 | ||
Health-related quality of life in patients with insomnia treated with zopiclone. | Q53633945 | ||
Residual symptoms in depressed patients who respond acutely to fluoxetine. | Q53933212 | ||
Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year | Q69993497 | ||
P433 | issue | 1 | |
P304 | page(s) | PCC.08r00743 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Primary Care Companion to the Journal of Clinical Psychiatry | Q15751574 |
P1476 | title | Why treat insomnia? | |
P478 | volume | 12 |
Q30397078 | A pilot study of audio-visual stimulation as a self-care treatment for insomnia in adults with insomnia and chronic pain |
Q90457543 | An Assessment of Medical Practitioners' Knowledge of, Experience with, and Treatment Attitudes Towards Sleep Disorders and Nightmares |
Q28395273 | Associations between Poor Sleep Quality and Stages of Change of Multiple Health Behaviors among Participants of Employee Wellness Program |
Q39375201 | Insomnia as a Precipitating Factor in New Onset Mental Illness: a Systematic Review of Recent Findings |
Q90294885 | Perceived racial discrimination and risk of insomnia among middle-aged and elderly Black women |
Q34666714 | Randomized placebo-controlled trial of cognitive behavioral therapy and armodafinil for insomnia after cancer treatment |
Q37627140 | Short sleep duration and insomnia associated with hypertension incidence |
Q93181335 | The assessment and management of insomnia: an update |
Q36117951 | The options available in cognitive behavioral therapy to prevent chronification of insomnia |
Q39799383 | Wake up to insomnia: future approaches to the management of insomnia |
Search more.